Company Overview of EPIX Pharmaceuticals, Inc.
Key Executives for EPIX Pharmaceuticals, Inc.
|Elkan R. Gamzu Ph.D.||49 Relationships||Chief Executive Officer, President, and Director||73|
|Ally Cantor||No Relationships||Director of Marketing Team||--|
|Mike Gnojewski||No Relationships||Director of Marketing Team||--|
|Tom Megerian M.D., Ph.D.||No Relationships||Executive Director of Clinical Research||--|
EPIX Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Elkan R. Gamzu Ph.D.||49 Relationships||EPIX Pharmaceuticals, Inc.||73|
|Mark W. Leuchtenberger||27 Relationships||Chiasma, Inc.||59|
|Tamas Bartfai Ph.D.||48 Relationships||The Scripps Research Institute||--|
|Ian F. Smith CPA, ACA||49 Relationships||Vertex Pharmaceuticals Incorporated||50|
|Michael Gilman Ph.D.||80 Relationships||Padlock Therapeutics, Inc.||61|
EPIX Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee CPA, ACA||Ian F. Smith||49 Relationships||1 Executives|
|Compensation Committee||Mark W. Leuchtenberger||27 Relationships||2 Executives|
|Advisory Board Ph.D.||Tamas Bartfai||48 Relationships||8 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
INDUSTRY EXECUTIVE CHANGESThere is no Executive Change data available.
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.